Özet:

Childhood obesity is one of the most important child health problems that are increasing around the world. Dislipidemia, accompanied by obesity, is a risk factor for atherosclerotic diseases in adulthood. In this study, we studied the availability of the neutrophil-lenfocytes (NLO) and platelet-lenfocytes (PLO) in children forecasting dyslipidemia, which is a serious complication of obesity. Method: In our Hospital Children's Health and Diseases Clinic, obesity diagnosed in the age of 11-17 was examined as retrospective in 207 cases and 50 cases without any disorders and a full blood test for routine purposes. The gender of the cases, age, examination findings were recorded. In the full blood count taken in the first application in obese children, the levels of leukocytes, hemoglobin, thrombocytes, average volume of thrombocytes, neutrophils and lymphocytes were evaluated. NLO and PLO are calculated. Hunger blood sugar and hunger insulin, serum aminotransferase values and lipid profile were recorded. Results: Dislipidemia was detected in 99 of 207 obesity cases (47.82) while dislipidemia was detected in 108 cases (52.18%). The symptoms of dyslipidemia were higher than the systolic blood pressure, diastolic blood pressure and hunger levels of insulin than the non-dislipidemia group. The PLO average of the dislipidemic group is 112.75±39.11, the PLO average of the non-dislipidemic group is 104.78±31.38, the PLO average of the control group is 110.20±39.35, and there is no statistically significant difference between the PLO average of the groups (p=0.353). The average NLO in the dislipidemic group was 1.52±0.69, in the non-dislipidemic group 1.66±0.81, in the control group 1.72±1.26. There was no statistically significant difference between the NLO average of the three groups (p=0,295). In our study, there was no connection between PLO and NLO and dyslipidemia in obese children.

Anahtar Kelimeler: